South Korean medical AI company Vuno has recently secured 10 billion won ($6.9 million) in strategic investment for its ...

Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...

Implantables net sales were $474 million, an increase of 4%. Excluding favorable currency impacts of 2%, Implantables net sales increased 2% constant currency. This growth reflects strong performance ...

Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual g ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsByron Jeffers - VP, Treasurer & Head of ...

A misinterpreted requirement or a missed edge case could take months to unwind. That reality shaped behavior. Teams debated longer. Documents grew heavier. Product requirements documents (PRDs), in ...

The world's most critical challenges are accelerating at a rapid pace. The R&D methods tasked with solving them are not—until ...

Company entering 2026 with the potential to deliver multiple value-driving milestones, including data readouts from ARV-102, ARV-806, and ...

The study, named IDEAL ( IaDademstat treatment for EssentiAL thrombocythemia ), is a multicenter, single-arm Phase II study to be conducted in Spain in adult patients with ET who are ...

Design engineers can use AI-driven simulation to overcome bottlenecks and accelerate materials discovery with hybrid workflow ...